Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine and Zidovudine for HIV
NCT00002110Phase 2Completed
- Sponsor
- Mylan
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cysteamine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Mylan. Primary endpoint: Safety and Tolerance. Status: completed.
02
Drugs
cysteamine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002110.